Sean Aylmer

So Altair invests in life sciences infrastructure across Asia.

So, you know, sort of pharmaceutical companies.

I mean, very broad, really.

But also Brisbane.

And so we have a chat to him about why Australia, why Brisbane, and how that city has become a healthcare and biotech hub.

Thank you, Sean.

Welcome to Fear and Greed Q&A, where we ask and answer questions about business, investing, economics, politics, and more.

I'm Sean Aylmer.

Singapore-based Altia Investments, A-L-T-E-A, Altia Investments, has spent years building and investing in life sciences infrastructure across Asia.

Now, it's making a major bet on Brisbane with the launch of the new life science incubator at QIMR Berghofer.

Brisbane is fast becoming a healthcare and biotech hub for Australia in medical and pharmaceutical products.

Growth in the city has occurred seven times faster than the rest of the country.

Fear and Greed is working with the Brisbane Economic Development Agency to explore exactly why global companies are choosing to invest in Brisbane.

John Ratcliffe is CEO of Altair Investments.

He spends his time sometimes in Queensland, sometimes in Singapore.

Coming to me from Singapore this morning, John, welcome to Fear and Greed Q&A.

Thanks very much.

John, tell me about the Life Science Incubator.

What's the vision behind it?

So QIMR, we must say Queensland Institute of Medical Research, just for those who don't know the acronym.